QuintilesIMS Blog

Fresh ideas and insights from our experts around the globe

For some patients and carers, home visits from a nurse may be the only support and contact they can rely on.
David Cameron
Susan Tansey
Developing drugs for rare diseases is challenging, but the support from patients and families will help to drive breakthroughs.
Read More
Christina Mack
Understanding emerging therapies in the real-world: challenges and opportunities.
Read More
Rupert Dixon
How a virtual R&D model is giving small and mid-sized companies the resource to bring their assets to market.
Read More
Anke van Engen
The adaptive pathway offers a number of real benefits, but sponsors must be prepared to face challenges in demonstrating the safety and effectiveness of treatments brought to market through this approach.
Read More
Randy Thomas
Barbara Gillespie
How success with migalastat demonstrates the value of using genomic testing criteria across multiple disease categories.
Read More
Jeff Keefer
How patient reported outcomes and global trials are giving new hope to sickle cell disease patients who haven’t seen a new treatment in decades.
Read More
In the new era of clinical development, decisions are all data driven, and the mistakes that add millions of dollars to drug development projects will soon be a distant memory.
Read More
Siva Nadarajah
A new platform to validate social media trends is helping biopharmaceutical companies make the most of this valuable source of data.
Read More